Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)

ClinicalTrials.gov ID: NCT00449150

Public ClinicalTrials.gov record NCT00449150. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cetrorelix Pamoate Intermittent Intramuscular (IM) Dosage Regimens in Patients With Symptomatic BPH: a 1 Year Placebo-controlled Efficacy Study and Long-term Safety Assessment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Benign Prostatic Hypertrophy (BPH) is a common and bothersome condition of aging men. It is characterized by an enlargement of the prostate occurring in human male over the age of 50 which increases in prevalence with age, and among those aged 50 to 80, about 40% report moderate or severe urinary symptoms of prostatism. The aim of treatment is to improve patients' quality of life which primarily depends on the severity of the symptoms of BPH. Current treatments of BPH have a benefit / risk ratio which leaves room for improvement. For this study, study medication (Cetrorelix pamoate or placebo) is administered by injection in the buttocks (Intramuscular). All patients completing the double-blind portion (Week 0 to 52) are eligible to receive the active drug during the open-label part of the study (Week 52 to 90).

Study identification

NCT ID
NCT00449150
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
AEterna Zentaris
Industry
Enrollment
667 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2007
Primary completion
May 31, 2009
Completion
Nov 30, 2009
Last update posted
Aug 2, 2018

2007 – 2009

United States locations

U.S. sites
46
U.S. states
24
U.S. cities
42
Facility City State ZIP Site status
Medical Affiliated Research Center, Inc. Huntsville Alabama 35801
Urology Group of Westrn Arkansas Fort Smith Arkansas 72901
South Orange County Medical Research Center Laguna Hills California 92653
California Professionnal Research Newport Beach California 92660
William G. Moseley San Diego California 92103
West Coast Clinical Research Tarzana California 91356
Western Clinical Research, Inc. Torrance California 90505
Urology Research Options Aurora Colorado 80012
Urologic Oncology Aurora Colorado 80045-0510
Genitourinary Surgical Consultants Denver Colorado 80220
Connecticut Clincal Research Center Middlebury Connecticut 06762
South Florida Medical Research Aventura Florida 33180
Tampa Bay Medical Research Clearwater Florida 33761
Atlantic Urological Associates Daytona Beach Florida 32114
Miami VACM Miami Florida 33125-1693
Florida Healthcare Research Ocala Florida 34474
Florida Urologist Specialists Sarasota Florida 34237
Southeastern Research Group Tallahassee Florida 32308
Southwestern Medical Research Institute Columbus Georgia 31904
Northwestern University Feinberg School of Medecine Chicago Illinois 60611
Welborn Clinic Evansville Indiana 47713
Northeast Indiana Research, LLC Fort Wayne Indiana 46825
Kansas City Urology Care Overland Park Kansas 66211
Four Rivers Clinical Research Paducah Kentucky 42003
Myron I. Murdock M.D. LLC Greenbelt Maryland 20770
Michigan Institute of Urology Saint Clair Shores Michigan 48081
Washington University St Louis Missouri 63110
Metropolitan Urological Specialists St Louis Missouri 63136
Quality Clinical Research Omaha Nebraska 68114
Delaware Valley Urology, LLC Woodlane New Jersey 08060
Urology Group Of New Mexico Albuquerque New Mexico 87109
Medical & Clinical Research Associates Bay Shore New York 11706
Urological Surgeons of Long Island, Clinical Research Division Garden City New York 11530
New York University School of Medecine New York New York 10016
University Urology New York New York 10016
Hudson Valley Urology Poughkeepsie New York 12601
Northeast Urology Research Concord North Carolina 28025
Parkhurst Research Oganization Inc. Bethany Oklahoma 73008
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Vanderbilt University medical Center Nashville Tennessee 37232
Corpus Christi Urology Group Corpus Christi Texas 78404
Urology Clinics of North Texas Dallas Texas 75231
University of Texas Southwestern Medical Center, Department of Urology Dallas Texas 75390-9110
Institute and the Texas Prostate Center Houston Texas 77030
Urology San Antonio Research, PA San Antonio Texas 78229
Integrity Medical Research Mountlake Terrace Washington 98043

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00449150, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2018 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00449150 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →